ArticleJournal of the Royal Society, Interface2025
Cancer model with moving extinction threshold reproduces real cancer data.
Article in Journal of the Royal Society, Interface, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cancer model with moving extinction threshold reproduces real cancer data.Journal of the Royal Society, Interface · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
We propose a simple dynamic model of cancer development that captures carcinogenesis and subsequent cancer progression. A central idea of the model is to include the immune response to cancer, which leads to the emergence of an extinction threshold. We first identify the limitations of commonly used extinction threshold models from population biology in reproducing typical cancer progression. We then address these limitations by deriving a new model that incorporates: (i) random mutations of stem cells at a rate that increases with age and (ii) immune response whose strength may also vary over time. Our model accurately reproduces a wide range of real-world cancer data: the typical age-specific cumulative risk of most human cancers, the progression of breast cancer in mice and the unusual age-specific cumulative risk of breast cancer in women. In the last case, we model the different immune response at different phases of the menstrual cycle and menopausal treatment and show that this leads to a moving extinction threshold. This approach provides new insights into the effects of hormone replacement therapy and menstrual cycle length on breast cancer in women. More generally, it can be applied to a variety of other cancer scenarios where the immune response or other important factors vary over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.